Redsense releases Aktiespararna CEO interview following Q4 2025 report

Halmstad, Sweden, February 19, 2026 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces that a video interview with CEO Sebastien Bollue has been published by Aktiespararna.

In the interview, Sebastien Bollue comments on the recently released Q4 2025 report, reflects on the past year, and provides priorities for 2026.

The interview is available on the Aktiespararna website:  https://www.aktiespararna.se/analyser/vd-intervju-redsense-medical

It is also accessible via the following link: https://www.youtube.com/watch?v=YEQi1QQTYg8